Author

Jiafeng Zhu

ORCID 0000-0002-6876-5988Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:perturbation response prediction· 1 Research Focus:protein design· 1 Assay:protein sequence· 1

Frequent Co-Authors

Chijian ZuoiD· 2 shared Jiali YangiD· 2 shared Qiangbo Hou· 2 shared Zhenhua SuniD· 2 shared Chunxi LiuiD· 1 shared Daolei Li· 1 shared Jiaojiao SuniD· 1 shared Lixiang Wei· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Chijian ZuoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologybioRxivPreprintJun 20, 2022

Clean-PIE: a novel strategy for efficiently constructing precise circRNA with thoroughly minimized immunogenicity to direct potent and durable protein expression

Zonghao Qiu, Qiangbo Hou, Yang Zhao…·Chijian Zuo

Clean-PIE generates high-purity, low-immunogenic circRNAs that enable durable protein expression in vitro and in vivo.

27 citations

experimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintApr 22, 2022

Circular mRNA encoded PROTAC (RiboPROTAC) as a new platform for the degradation of intracellular therapeutic targets

Jiali Yang, Jiaojiao Sun, Jiafeng Zhu…·Chijian Zuo

This paper introduces RiboPROTAC, a new platform using circular mRNA to degrade intracellular proteins, demonstrating its effectiveness in degrading GFP and PCNA with functional and immunological effects.

11 citations

protein sequenceexperimental assay

𝕏 PostBluesky